Bold Therapeutics reports protection against chemotherapy-induced peripheral neuropathy with BOLD-100 anticancer agent

Adimab partner GSK receives additional marketing approvals for depemokimab

Seragon reports SRN-901 longevity drug data

Lunai Bioworks and Geneial enter into LOI to build rare disease patient cohorts for drug development partnerships

Circio partners with Acuitas to evaluate in vivo CAR-T cell therapy technology

GSK strengthens pulmonary hypertension pipeline with USD950m acquisition of 35Pharma

Poolbeg Pharma secures MHRA approval for POLB 001 trial as US research highlights multi-billion dollar potential

Asgard Therapeutics appoints chief medical officer

Mestag Therapeutics to present targeted LTBR agonist MST-0312 at AACR Annual Meeting

CrossBridge Bio to be acquired by Eli Lilly

Groupe Rocher partners with Dassault Systèmes to accelerate cosmetics innovation using virtual twin technology

hVIVO signs influenza human challenge trial agreement with Traws Pharma

IDEAYA Biosciences and Servier report positive results from Phase 2/3 trial of darovasertib/crizotinib combination

Hoth Therapeutics reports positive HT-VA CRADA data

Kelun-Biotech reports Phase II study results for sac-TMT at 2026 SGO